GLP-1 / Metabolic
Semaglutide
Dosage
Semaglutide (CAS 910463-68-2) is a synthetic, acylated glucagon-like peptide-1 (GLP-1) receptor agonist engineered for an extended half-life through albumin binding.
Mechanism of action. In research models, semaglutide selectively activates the GLP-1 receptor, a key node of the incretin system. Studies focus on its effects on glucose-dependent insulin secretion, glucagon suppression, gastric-emptying models, and central satiety signaling.
Research applications. A standard single-agonist reference in metabolic and receptor-pharmacology research. Published clinical programs (SUSTAIN and STEP) characterized its effects on glycemic and body-weight endpoints in study subjects.
Supplied as a lyophilized powder, ≥99% HPLC purity; Certificate of Analysis available on request. Available for laboratory and research purposes only.
Identity & Purity Verified
Every batch tested for identity and purity
COA Available
Certificate of Analysis available by request
Secure Shipping
Temperature-conscious packaging for stability
Need a Certificate of Analysis? Request by email.
Storage & Handling
- Store at -20°C for long-term stability
- Avoid repeated freeze-thaw cycles
- Protect from light and moisture
- Follow the storage instructions printed on the product label
Quality Assurance
- Independent third-party laboratory testing
- Certificate of Analysis available by request
- HPLC and mass spectrometry verification
- Batch-to-batch consistency verified
Related Research Compounds
Explore more high-purity peptides from our catalog.
